Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study

YORGANCIOĞLU A. A.

SABA overuse in asthma, is it still a burden? Where we stand in disease control and management, 18 Kasım 2022, (Tam Metin Bildiri)